Prescriptions on Demand
- 10 September 2019
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 322 (10), 925-926
- https://doi.org/10.1001/jama.2019.9889
Abstract
This Viewpoint discusses advantages and theoretical harms of direct-to-consumer drug telemedicine, whereby patients obtain prescription drugs through online visits, and calls for monitoring of for-profit DTC direct-to-consumer telemedicine ventures (eg, Curology, Hims, Nurx, and The Pill Club) to ensure that quality and safety are not being sacrificed for convenience of care.Keywords
This publication has 1 reference indexed in Scilit: